Rolipram, a phosphodiesterase 4 inhibitor, stimulates inducible cAMP early repressor expression in osteoblasts
about
Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments.NCS 613 exhibits anti-inflammatory effects on PBMCs from lupus patients by inhibiting p38 MAPK and NF-κB signalling pathways while reducing proinflammatory cytokine production.NCS 613, a potent and specific PDE4 inhibitor, displays anti-inflammatory effects on human lung tissues.
P2860
Rolipram, a phosphodiesterase 4 inhibitor, stimulates inducible cAMP early repressor expression in osteoblasts
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Rolipram, a phosphodiesterase ...... ssor expression in osteoblasts
@en
Rolipram, a phosphodiesterase ...... ssor expression in osteoblasts
@nl
type
label
Rolipram, a phosphodiesterase ...... ssor expression in osteoblasts
@en
Rolipram, a phosphodiesterase ...... ssor expression in osteoblasts
@nl
prefLabel
Rolipram, a phosphodiesterase ...... ssor expression in osteoblasts
@en
Rolipram, a phosphodiesterase ...... ssor expression in osteoblasts
@nl
P2093
P2860
P1476
Rolipram, a phosphodiesterase ...... ssor expression in osteoblasts
@en
P2093
Eun Sook Cho
Ja Heon Yu
Mi Sun Kim
Mijung Yim
P2860
P304
P356
10.3349/YMJ.2005.46.1.149
P577
2005-02-01T00:00:00Z